Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Prescription Monitoring

Governor Christie Strengthens New Jersey’s Prescription Monitoring Program to Further Curb Prescription Drug Abuse

Trenton, NJ, July 20, 2015 ― Empowering healthcare professionals with effective tools to join the fight against prescription drug abuse, Governor Chris Christie signed legislation that expands the New Jersey Attorney General’s Division of Consumer Affairs Prescription Monitoring Program (PMP), an online database that tracks the prescription sale of drugs classified as controlled dangerous substances (CDS).

The bill, S1998, expands existing law with regard to access, registration, and utilization of the NJPMP. The new changes will help prevent “doctor shopping” that often occurs with prescription and opioid abuse.

“We have taken great strides in the fight against opiate abuse through a comprehensive strategy that encourages healthcare professionals, treatment providers, law enforcement, and members of the public to each embrace their role in addressing this healthcare crisis,” Governor Christie said. Continue reading

Attorney General Report: 20,000 NJ Physicians Signed Up for Prescription Monitoring Program Access in 2014

Newark, NJ, December 12, 2014 ― Approximately 20,000 New Jersey physicians and 5,000 other licensed healthcare practitioners this year gained direct access to the New Jersey Prescription Monitoring Program (NJPMP), a significant milestone in the fight against the deadly epidemic of opiate abuse.

As of today, 85 percent of New Jersey’s physicians – or 25,501 of the State’s eligible physicians – are able to access the NJPMP. This represents a 467 percent increase since December 2013, when approximately 4,500 physicians had NJPMP access.

Additionally, 56 percent of all healthcare practitioners in New Jersey – or 35,500 of the State’s eligible prescribers and pharmacists of all kinds – have direct access to the prescription-tracking database.  This represents a 256 percent increase since December 2013, when 9,965 healthcare practitioners had access to the NJPMP. Continue reading